Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 66 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

18%

12 trials in Phase 3/4

Results Transparency

0%

0 of 9 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

34Total
Not Applicable (21)
P 1 (1)
P 3 (5)
P 4 (7)

Trial Status

Recruiting33
Not Yet Recruiting11
Completed9
Unknown6
Active Not Recruiting4
Enrolling By Invitation2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 9 completed trials

Clinical Trials (66)

Showing 20 of 20 trials
NCT06578234Phase 4RecruitingPrimary

Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses

NCT06337461CompletedPrimary

Computational mOdelliNg of myoCardial pERfusion to Improve ouTcome Prediction Based on cOronary Artery Stenosis and Atherosclerotic Plaque Burden Assessment by Computed Tomography

NCT07711106Not ApplicableRecruiting

"Expert IVUS-Eye" vs. IVUS-guided Left Main Bifurcation PCI

NCT07708805Not ApplicableNot Yet Recruiting

Quantitative Myocardial Perfusion Imaging Assessment by SPECT/CT

NCT07696533Not ApplicableRecruitingPrimary

ULTIMATE Study (Carotid Ultrasound Vs CT Coronary Calcium Scoring to Reclassify Symptomatic Patients With Chronic Coronary Syndrome)

NCT07195149Phase 3RecruitingPrimary

Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)

NCT07615868Phase 1RecruitingPrimary

A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Chinese Adults With Chronic Coronary Syndrome

NCT07577518Not ApplicableNot Yet RecruitingPrimary

Comparison of the Incidence of Major Cardiovascular Events Between the Combination of Percutaneous Intervention and Optimal Drug Therapy and the Optimal Drug Therapy Alone in Patients With Chronic Coronary Syndrome

NCT07641257Not Yet Recruiting

Effects of Icosapent Ethyl on Coronary Plaque, Inflammation, and Ventricular Remodeling

NCT07638137Recruiting

Advanced Invasive Diagnosis Strategy for Post-PCI Patients With Stable Coronary Syndromes Undergoing Coronary Angiography

NCT07291609RecruitingPrimary

Microplastics and Nanoplastics in Patients With Chronic Coronary Syndromes

NCT07620925Recruiting

Derivation and Validation of the Aortic Valve Echocardiographic Calcium Score to Confirm Severe Aortic Stenosis: the Echo-AVCS Study

NCT07592312Not ApplicableNot Yet Recruiting

Computed Tomography Angiography Based Procedural Planning in PeRcutaneOus Coronary InterVEntion

NCT07572747Phase 3Not Yet RecruitingPrimary

Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf Countries

NCT06736665Not ApplicableRecruiting

Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified Coronary Nodules (ORBIT-SHOCK).

NCT07471867Phase 4RecruitingPrimary

Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PercuTaneous CoronAry InteRvention

NCT07329699Not ApplicableRecruiting

Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)

NCT07543185Not ApplicableNot Yet RecruitingPrimary

Right Dorsolateral Prefrontal Cortex Closed-loop Neurofeedback for Anxiety in High-ischaemic-risk Chronic Coronary Syndrome

NCT07472634CompletedPrimary

Evaluation of the Performance of the Cardiolens® Platform, Which Utilizes a Non-Invasive Combined Anatomical and Functional CCTA-based Assessment in Patients With Suspected CCS

NCT07428382Completed

Development and Validation of Care Pathway Quality Indicators for Stroke and Chronic Coronary Syndrome Using French Administrative Healthcare Database (DELIQUA-CNV)

Scroll to load more

Research Network

Activity Timeline